How NutriShield Helps Support NAD+ and Mitochondrial Health
A molecule called NAD+. or in its full form Nicotinamide Adenine Dinucleotide, is a high energy molecule generated from food intake. NAD+ is essential for life, the creation of energy and can ‘significantly restore mitochondrial function4. But it declines as we get older2.
This is a problem - because normally functioning mitochondria are vital for heart health. A recent study shows that reduced levels of NAD+ can accelerate heart disease. Lower levels are also linked to poorer metabolism and therefore weight gain.
Another implication is for cognitive health. The brain uses a lot of energy – it’s 3% of your body weight but consumes 20% of your energy. Therefore, brain cells – neurons – contain a lot of mitochondria and if these are not fully functioning, then cognitive function can be impaired.
Increasing NAD +
You cannot supplement directly with NAD+ because it breaks down in the gut. So recent logic has been to supplement with the precursors of NAD+ to increase its levels – and therefore boost energy and slow ageing2.
There are various forms of vitamin B3 that do that – including Nicotinamide Riboside4(NR) , Nicotinamide Mononucleotide (NMN) and Nicotinamide– the form of B3 in Nutrishield
Since inflammation promotes the decline of NAD, the numerous anti-inflammatory nutrients in Nutrishield will help stem the decline. These include the phyto-nutrients in green tea, grapeseed and bilberry extract, and curcumin as well as vitamins A C, E , D3 and selenium and magnesium.
No one nutrient on its own is going to make a big difference to your health – it’s the synergistic impact of many working together that is key to health.
- Mitochondrial complex I deficiency increases protein acetylation and accelerates heart failure - PubMed (nih.gov)
- NAD + Intermediates: The Biology and Therapeutic Potential of NMN and NR - PubMed (nih.gov)
- Reversal of endothelial dysfunction by nicotinamide mononucleotide via extracellular conversion to nicotinamide riboside - PubMed (nih.gov)
- Nicotinamide Riboside for the Prevention and Treatment of Doxorubicin Cardiomyopathy. Opportunities and Prospects - PubMed (nih.gov)